Alpelisib Available Phase N/A Trials for HR+ Advanced or Metastatic Breast Cancer

IndicationsStatusPurposePhase
AvailableNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03706573Managed Access Program to Provide Alpelisib for Patients With HR+ Advanced or Metastatic Breast Cancer